the plasma lipid and serum uric acid lowering effect of halofenate ( mk-185 , 1 g/day ) was compared with the action of clofibrate ( 2 g/day ) in a double-blind 1-yr study in 23 patients with type 2 , 3 , 4 , and 5 hyperlipoproteinemia .
C0009002
clofibrate
C0020476
hyperlipoproteinemia